Role of the Na+/K+/2Cl- cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma

doi:10.3748/wjg.v20.i22.6844

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 22

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8111)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-4) series.

Item

Count

PDF

562

WORD

420

HTML

4531

Figures (1-7)

324

Tables (1-4)

239

Sum=6076

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

964

Download

1071

Sum=2035

Jun 14, 2014 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (40)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jun 14, 2014; 20(22): 6844-6859
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6844

Table 1 Correlations between clinicopathological parameters and Na⁺/K⁺/2Cl^- cotransporter 1 expression

Variable		NKCC1 expression		P value
Variable		Low grade	High grade
Age (yr)	< 60	12	10	P value	0.1874
	≥ 60	16	30
Gender	Male	25	32	0.5049
	Female	3	8
Location of tumor	Ce/Ut	4	3	0.4346
	Mt/Lt/Ae	24	37
Tumor size (mm)	< 50	18	30	0.4206
	≥ 50	10	10
Histological type	Differentiated type SCC	25	21	0.0015^a
	Poorly differentiated type SCC	3	19
pT	pT1	10	21	0.2191
	pT2-3	18	19
pN	negative	13	20	0.8095
	positive	15	20
pStage	I	6	16	0.1231
	II-III	22	24
Ki-67 labeling index		28.7 ± 2.3	29.9 ± 2.0	0.6834

Ce: Cervical esophagus; Ut: Upper thoracic esophagus; Mt: Middle thoracic esophagus; Lt: Lower thoracic esophagus; Ae: Abdominal esophagus; pT: Pathological T stage; pN: Pathological N stage; pStage: Pathological stage; SCC: Squamous cell carcinoma;

^aP < 0.05 vs control, Fisher’s exact test.

Table 2 Twenty genes displaying the highest change in expression levels in Na⁺/K⁺/2Cl^- cotransporter 1 depleted KYSE170 cells

Gene Symbol	Gene ID	Gene Name	Fold Change
Upregulated Genes
C18orf34	NM_001105528	Chromosome 18 open reading frame 34	155.49
KCNA6	NM_002235	Potassium voltage-gated channel, shaker-related subfamily, member 6	140.4
CCDC147	NM_001008723	Coiled-coil domain containing 147	105.98
C20orf202	NM_001009612	Chromosome 20 open reading frame 202	86.17
A1CF	NM_138933	APOBEC1 complementation factor	70.98
SH3GL2	NM_003026	SH3-domain GRB2-like 2	70.93
PTGFR	NM_001039585	Prostaglandin F receptor (FP)	66.99
NDN	NM_002487	Necdin homolog (mouse)	66.45
INPP5D	NM_001017915	Inositol polyphosphate-5-phosphatase, 145 kDa	52.83
CYP2E1	NM_000773	Cytochrome P450, family 2, subfamily E, polypeptide 1	52.44
AGBL3	NM_178563	ATP/GTP binding protein-like 3	50.88
UBTFL1	NM_001143975	Upstream binding transcription factor, RNA polymerase I-like 1	47.88
PADI2	NM_007365	Peptidyl arginine deiminase, type II	46.83
CCR1	NM_001295	Chemokine (C-C motif) receptor 1	44.86
ARC	NM_015193	Activity-regulated cytoskeleton-associated protein	44.41
COLEC10	NM_006438	Homo sapiens collectin sub-family member 10 (C-type lectin)	44.28
DNAH6	NM_001370	Dynein, axonemal, heavy chain 6	41.96
BOLL	NM_033030	Bol, boule-like (Drosophila)	41.31
CORO2B	NM_006091	Coronin, actin binding protein, 2B	41.04
MUC7	NM_152291	Mucin 7, secreted	36.97
Downregulated Genes
NPFFR1	NM_022146	Neuropeptide FF receptor 1	-54.97
LRRFIP1	NM_001137550	Leucine rich repeat (in FLII) interacting protein 1	-44.72
PPIL6	NM_173672	Peptidylprolyl isomerase (cyclophilin)-like 6	-44.46
CRHR2	NM_001883	Corticotropin releasing hormone receptor 2	-39.78
CMTM2	NM_144673	CKLF-like MARVEL transmembrane domain containing 2	-39.62
C5	NM_001735	Complement component 5	-39.13
KCNMA1	NM_001014797	Potassium large conductance calcium-activated channel, subfamily M, alpha member 1	-38.59
HESX1	NM_003865	HESX homeobox 1	-33.03
SLC22A2	NM_003058	Solute carrier family 22 (organic cation transporter), member 2	-32.49
WNT8B	NM_003393	Wingless-type MMTV integration site family, member 8B	-32.17
GRIA1	NM_000827	Glutamate receptor, ionotropic, AMPA 1	-31.27
ZNF367	NM_153695	Zinc finger protein 367	-30.04
GPR128	NM_032787	G protein-coupled receptor 128	-29.88
SLC12A2	NM_001046	Solute carrier family 12 (sodium/potassium/chloride transporters), member 2	-28.92
KCNG2	NM_012283	Potassium voltage-gated channel, subfamily G, member 2	-28.3
ECT2L	NM_001077706	Epithelial cell transforming sequence 2 oncogene-like	-27
ERMN	NM_020711	Ermin, ERM-like protein	-26.61
DPP10	NM_020868	Dipeptidyl-peptidase 10 (non-functional)	-26.58
TSPAN7	NM_004615	Tetraspanin 7	-25.54
APOA1	NM_000039	Apolipoprotein A-I	-25.21

Table 3 Top biological functions, canonical pathways, and networks of Na⁺/K⁺/2Cl^- cotransporter 1 according to Ingenuity Pathway Analysis

Top Biological Functions
Diseases and disorders
Name	P value	Number of molecules
Cancer	2.08E-12 - 1.59E-02	277
Gastrointestinal disease	8.03E-12 - 1.60E-02	149
Reproductive system disease	2.25E-09 - 1.57E-02	138
Hematological disease	1.72E-06 - 1.22E-02	70
Hereditary disorder	2.10E-06 - 1.57E-02	120

Molecular and cellular functions
Name	P value	Number of molecules
Cell cycle	1.06E-20 - 1.60E-02	158
Cellular assembly and organization	1.06E-20 - 1.36E-02	111
DNA replication, recombination, and repair	1.06E-20 - 1.16E-02	133
Cellular movement	8.36E-11 - 1.51E-02	82
Cell death	2.98E-06 - 1.56E-02	216
Top canonical pathways
Name	P value	Ratio
Role of BRCA1 in the DNA damage response	9.79E-6	12/65 (0.185)
Mitotic roles of Polo-Like kinase	7.37E-5	11/69 (0.159)
Estrogen-mediated S-phase entry	4.91E-4	6/28 (0.214)
Cell Cycle: G2/M DNA damage checkpoint regulation	5.07E-4	8/49 (0.163)
Role of CHK proteins in cell cycle checkpoint control	5.37E-4	9/56 (0.161)

Top networks
Associated network functions	Score
Cellular assembly and organization; DNA replication, recombination, and repair; Cell cycle	47
Cellular assembly and organization, Cell cycle, DNA replication, recombination, and repair	43
Cell cycle; DNA replication, recombination, and repair; Cancer	37
Digestive system development and function, organismal injury and abnormalities, cellular function and maintenance	37
Cellular assembly and organization; DNA replication, recombination, and repair; Cardiovascular disease	35

Table 4 Cell growth-related genes with expression levels in KYSE170 cells that were changed by the depletion of Na⁺/K⁺/2Cl^- cotransporter 1

Gene symbol	Gene ID	Biological functions		Fold change
Gene symbol	Gene ID	Cell growth and proliferation	Cell cycle
Upregulated genes				Fold change
NDN	NM_002487	●		66.45
INPP5D	NM_001017915	●	●	52.83
CCR1	NM_001295	●		44.86
COL1A2	NM_000089	●		36.72
EDAR	NM_022336		●	35.86
RBP4	NM_006744	●		30.40
DCLK1	NM_004734		●	28.95
RARRES1	NM_002888	●		22.92
FMOD	NM_002023	●		22.85
BARX1	NM_021570	●		21.47
MAPK10	NM_138980	●		20.00
ADORA2A	NM_000675	●		18.78
CHRNA7	NM_001190455	●	●	18.47
SOX10	NM_006941	●		18.03
FGF20	NM_019851	●		16.73
FAM5C	NM_199051	●	●	14.35
MBD2	NM_015832	●		12.13
EGF	NM_001963	●	●	11.50
TLR5	NM_003268	●		11.35
TNN	NM_022093	●		10.98
SLC1A2	NM_004171	●		10.74
CD36	NM_001001547	●		10.43
CD52	NM_001803	●		10.34
NR2E3	NM_016346	●		10.31
PLCB1	NM_182734		●	10.26
MYCN	NM_005378	●	●	10.23
ZNF365	NM_199451		●	10.12
ERG	NM_004449	●		10.04
MSH4	NM_002440		●	10.03
DMRT1	NM_021951		●	9.61
RNF128	NM_194463	●		9.37
CD69	NM_001781	●		8.89
PDE3A	NM_000921	●	●	8.58
ACVR1C	NM_145259	●		8.57
SPI1	NM_001080547	●	●	8.55
SH2D3C	NM_170600	●		8.53
IFNG	NM_000619	●	●	8.22
MRAS	NM_012219	●		8.20
MCF2L	NM_024979	●		7.43
RRAD	NM_004165	●	●	7.42
E2F5	NM_001951	●	●	7.32
BGN	NM_001711	●		7.13
KIFC1	NM_002263		●	7.02
ABCC6	NM_001171			6.98
SERPINE1	NM_000602	●		6.74
CIITA	NM_000246	●		6.74
GJB6	NM_006783	●		6.45
TP53INP1	NM_033285	●	●	6.38
GHRL	NM_016362	●		6.30
CCNG2	NM_004354	●	●	6.29
RORC	NM_005060	●		6.24
NCF1	NM_000265	●		6.24
NFATC4	NM_001136022	●		6.15
CHRM5	NM_012125	●		6.01
HMOX1	NM_002133	●	●	6.00
IL18RAP	NM_003853	●		5.98
C8orf4	NM_020130	●		5.95
L1CAM	NM_024003	●		5.87
TNFSF8	NM_001244	●		5.85
MSMB	NM_002443	●		5.77
ITPR1	NM_002222	●		5.77
ITGAL	NM_002209	●	●	5.73
INHBA	NM_002192	●	●	5.53
HEYL	NM_014571	●		5.38
JAK3	NM_000215	●	●	5.30
MMP13	NM_002427	●		5.23
NNMT	NM_006169	●		5.06
BNIPL	NM_138278	●		4.86
LTC4S	NM_145867		●	4.74
MMP24	NM_006690	●		4.72
MMP1	NM_002421	●		4.66
CD19	NM_001770	●	●	4.52
ADC	NM_052998	●		4.46
TGFBR1	NM_004612	●	●	4.33
RHOB	NM_004040	●		4.32
CDKN1C	NM_000076	●	●	4.30
HOXB13	NM_006361	●	●	4.20
IPMK	NM_152230	●		4.07
BMF	NM_001003940	●		4.06
VTCN1	NM_024626	●	●	4.05
CEACAM1	NM_001712	●		2.97
TSSK3	NM_052841		●	2.00
Downregulated genes
CRHR2	NM_001883	●		-39.78
C5	NM_001735	●	●	-39.13
KCNMA1	NM_001014797	●		-38.59
GRIA1	NM_000827	●		-31.27
SLC12A2	NM_001046	●		-28.92
APOA1	NM_000039	●		-25.21
PRKAR2B	NM_002736	●	●	-24.25
TF	NM_001063	●	●	-22.85
BRCA2	NM_000059	●	●	-22.04
AURKC	NM_001015878		●	-21.69
PLXNA4	NM_181775	●		-20.54
TYR	NM_000372	●		-20.39
BACH2	NM_021813	●		-20.01
KIF14	NM_014875		●	-18.06
HEY2	NM_012259	●		-18.01
TMPO	NM_003276	●	●	-15.97
FCGR3A	NM_000569	●		-15.18
ARF6	NM_001663			-15.09
MYBL1	NM_001080416	●	●	-14.60
CCNA1	NM_003914	●	●	-14.29
ESCO2	NM_001017420		●	-14.05
TOP2A	NM_001067	●	●	-13.91
CENPI	NM_006733		●	-13.87
ATAD2	NM_014109	●		-13.41
POSTN	NM_006475	●		-12.91
MKI67	NM_002417	●	●	-12.41
ABCB1	NM_000927	●	●	-12.15
KIF20B	NM_016195	●	●	-11.53
SPN	NM_001030288	●		-11.41
MAD2L1	NM_002358	●	●	-11.16
HLA-DPB1	NM_002121	●		-11.12
SGOL1	NM_001012410		●	-10.91
RRM2	NM_001034	●		-10.71
FANCD2	NM_033084	●	●	-10.55
FANCA	NM_001018112	●	●	-10.31
HDAC2	NM_001527	●	●	-9.94
NUF2	NM_145697		●	-9.76
CLSPN	NM_022111	●	●	-9.57
RAD54L	NM_003579		●	-9.47
KLHL13	NM_033495		●	-9.32
CCNA2	NM_001237	●	●	-9.13
MCM10	NM_182751	●	●	-9.11
MCTS1	NM_014060	●		-9.02
ANLN	NM_018685		●	-9.00
HMGB2	NM_002129	●	●	-8.86
VPREB1	NM_007128	●		-8.81
KIF4A	NM_012310		●	-8.78
SPC25	NM_020675		●	-8.75
ALOX5	NM_000698	●	●	-8.55
PBK	NM_018492	●		-8.20
TNFRSF11B	NM_002546	●		-8.20
CIT	NM_001206999		●	-8.17
HELLS	NM_018063	●	●	-8.1
CDC45	NM_003504	●	●	-8.07
DTL	NM_016448	●	●	-8.00
RGS3	NM_017790			-7.93
TYMS	NM_001071	●	●	-7.87
NDC80	NM_006101		●	-7.86
ERCC6L	NM_017669		●	-7.82
CENPE	NM_001813		●	-7.75
TTK	NM_003318	●	●	-7.74
SIM2	NM_009586		●	-7.61
KRT4	NM_002272	●		-7.55
RAD51AP1	NM_006479		●	-7.55
LTA	NM_000595	●		-7.51
PAK2	NM_002577	●	●	-7.50
SLC5A8	NM_145913	●		-7.41
BLM	NM_000057	●	●	-7.40
NUSAP1	NM_016359		●	-7.36
JDP2	NM_130469	●	●	-7.19
CASP3	NM_004346	●	●	-7.17
NEIL3	NM_018248	●		-7.17
POLH	NM_006502	●	●	-7.11
KIF20A	NM_005733	●	●	-7.08
MYO7A	NM_000260			-6.93
NRGN	NM_006176	●		-6.82
NCAPG	NM_022346	●	●	-6.78
CDCA8	NM_018101	●	●	-6.72
CEP55	NM_018131		●	-6.65
DLGAP5	NM_014750	●	●	-6.60
CDC25C	NM_001790	●	●	-6.59
ARL2BP	NM_012106	●		-6.58
IL12A	NM_000882	●	●	-6.53
MYH14	NM_001077186	●		-6.52
SKA1	NM_001039535		●	-6.46
CASC1	NM_018272		●	-6.44
HJURP	NM_018410		●	-6.42
TACC3	NM_006342	●	●	-6.33
ENPP3	NM_005021	●		-6.30
STIL	NM_001048166	●	●	-6.27
KNTC1	NM_014708		●	-6.26
NR1I2	NM_003889	●	●	-6.24
AKR1B10	NM_020299	●		-6.22
E2F2	NM_004091	●	●	-6.20
USP47	NM_017944	●		-6.14
KIF11	NM_004523	●	●	-6.09
E2F8	NM_024680	●	●	-6.05
PLK1	NM_005030	●	●	-6.02
CCDC6	NM_005436	●		-6.00
ORC6	NM_014321		●	-6.00
EXO1	NM_003686		●	-5.95
GPC5	NM_004466	●		-5.94
GSG2	NM_031965		●	-5.93
PRC1	NM_003981		●	-5.89
RAD51	NM_002875	●	●	-5.78
KIF2C	NM_006845	●	●	-5.71
TNFRSF13C	NM_052945	●		-5.70
BLZF1	NM_003666	●		-5.63
FEN1	NM_004111	●		-5.51
PLK4	NM_014264	●	●	-5.49
HAS2	NM_005328	●	●	-5.44
PKMYT1	NM_182687		●	-5.40
BUB1	NM_001211	●	●	-5.34
BUB1B	NM_001211	●	●	-5.34
NEK2	NM_002497	●	●	-5.33
IQGAP3	NM_178229		●	-5.27
SKA3	NM_145061		●	-5.23
PNN	NM_002687	●	●	-5.20
NTRK3	NM_001007156	●	●	-5.17
IL25	NM_022789	●		-5.09
UBE2C	NM_181803	●	●	-5.09
AURKB	NM_004217	●	●	-5.08
CDC6	NM_001254	●	●	-5.08
CDKN2C	NM_078626	●	●	-5.06
EDN2	NM_001956	●		-5.06
CDC20	NM_001255	●	●	-5.05
RRM1	NM_001033	●	●	-5.05
APC	NM_000038	●	●	-5.04
KIF15	NM_020242	●	●	-5.03
LMNB1	NM_005573	●		-5.02
NCAPG2	NM_017760		●	-4.96
CCNE2	NM_057749	●	●	-4.94
HMMR	NM_012484	●		-4.93
BRIP1	NM_032043	●		-4.90
ECT2	NM_018098	●	●	-4.89
CDT1	NM_030928	●	●	-4.87
MCAM	NM_006500	●		-4.82
LAG3	NM_002286	●	●	-4.78
ZWINT	NM_032997		●	-4.73
DCLK2	NM_001040260		●	-4.72
TRAIP	NM_005879	●		-4.71
SSTR2	NM_001050	●	●	-4.69
TXK	NM_003328	●		-4.65
TBC1D9	NM_015130	●		-4.63
IL1RN	NM_173843	●		-4.61
CDCA7	NM_031942	●		-4.56
STK38	NM_007271	●	●	-4.56
CDCA5	NM_080668	●	●	-4.54
E2F7	NM_203394	●		-4.54
FIGNL1	NM_001042762	●		-4.51
SMC4	NM_005496		●	-4.50
CYCS	NM_018947	●		-4.48
FBN1	NM_000138	●		-4.48
NCAPD3	NM_015261		●	-4.46
IL16	NM_172217	●	●	-4.44
PCNA	NM_002592	●	●	-4.42
FBXO5	NM_001142522		●	-4.37
CKAP2	NM_018204		●	-4.34
IL34	NM_152456	●		-4.34
PSRC1	NM_032636	●	●	-4.33
C11orf82	NM_145018		●	-4.32
CHRDL1	NM_145234		●	-4.31
RAD54B	NM_012415		●	-4.31
DIAPH3	NM_001042517		●	-4.29
AKR1C1	NM_001353	●		-4.26
INHBB	NM_002193	●		-4.25
MDM2	NM_002392	●	●	-4.25
PRKAA1	NM_206907	●		-4.25
MASTL	NM_032844		●	-4.23
MCM5	NM_006739	●		-4.21
CD2AP	NM_012120	●	●	-4.20
BRCA1	NM_007300	●	●	-4.18
TPX2	NM_012112	●	●	-4.15
FGFBP1	NM_005130	●		-4.14
EIF4G2	NM_001172705	●	●	-4.12
AURKA	NM_198433	●	●	-4.10
PTTG1	NM_004219	●	●	-4.08
ADRA1B	NM_000679	●	●	-4.07
RECQL4	NM_004260	●		-4.02
GJB2	NM_004004	●		-4.00
BIRC5	NM_001012271	●	●	-3.35
TERF1	NM_017489	●	●	-3.18
LRP1	NM_032832	●		-2.43
CDK1	NM_012395	●	●	-2.21
ARHGEF10	NM_014629		●	-2.08

Citation: Shiozaki A, Nako Y, Ichikawa D, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Marunaka Y, Otsuji E. Role of the Na⁺/K⁺/2Cl^- cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma. World J Gastroenterol 2014; 20(22): 6844-6859
URL: https://www.wjgnet.com/1007-9327/full/v20/i22/6844.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i22.6844